Table 2 Intra- and post-operative findings of patients by method of operation
Characteristic | ICG-D (n = 92) | CMF (n = 110) | P-value | |
|---|---|---|---|---|
Operation time (min)a | Mean (SD) | 9.27 (4.9) | 6.65 (3.9) | < 0.001 |
Number of resected SLNs | Mean (range) | 2.21 (1–9) | 1.82 (1–7) | 0.061 |
Pathological type | Ductal carcinoma in situ | 4 (4.3%) | 11(10.0%) | 0.112 |
Invasive ductal carcinoma | 83 (90.2%) | 90 (81.8%) | ||
Invasive lobular carcinoma | 0 (0%) | 4 (3.6%) | ||
Special type | 5 (5.4%) | 5 (4.5%) | ||
Estrogen receptor | Positive | 76 (82.6%) | 97 (88.2%) | 0.261 |
Negative | 16 (17.4%) | 13 (11.8%) | ||
Progesterone receptor | Positive | 67 (72.8%) | 90 (81.8%) | 0.126 |
Negative | 25 (27.2%) | 20 (18.2%) | ||
Herceptine score (HER2) | Positive | 15 (16.3%) | 11 (10%) | 0.163 |
Negative | 73 (79.3%) | 88 (80%) | ||
Unknown | 4 (4.3%) | 11 (10%) |